News/ R&D Novartis cues up Cosentyx as disease-modifying treatment for psoriasis Richard Staines auto-immune diseases, Celgene, Eli Lilly, Johnson & Johnson, Novartis, psoriasis 0 Comment Pharma begins early intervention trial after Cosentyx shows “disease modifying” properties Share X Novartis cues up Cosentyx as disease-modifying treatment for psoriasis https://pharmaphorum.com/news/novartis-thinks-early-intervention-key-psoriasis-market/